Zepbound (Tirzepatide) Zepbound is a once-weekly injection that targets two hormones, GLP-1 and GIP, for enhanced weight loss results
Besides, there has been an increase in the occurrence from 30.5% in previous years and 4.7% surge in severe obesity, thereby making it suitable for enhancing the semaglutide market growth in the region
With Semaglutide as part of our Weight Loss Management Program, youll not only see the changes on the scale but feel the difference in your energy, confidence, and overall well-being
A 65-year-old with type 2 diabetes faces different risks and benefits than a 35-year-old without metabolic disease
When Metformin alone has not adequately controlled a blood glucose level, in conjunction with diet and exercise, semaglutide can be considered